{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T16:34:41Z","timestamp":1787934881960,"version":"build-2784847793"},"publisher-location":"Cham","reference-count":44,"publisher":"Springer Nature Switzerland","isbn-type":[{"value":"9783031849879","type":"print"},{"value":"9783031849886","type":"electronic"}],"license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025]]},"DOI":"10.1007\/978-3-031-84988-6_10","type":"book-chapter","created":{"date-parts":[[2025,6,9]],"date-time":"2025-06-09T06:56:08Z","timestamp":1749452168000},"page":"177-191","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Hematopoietic Stem Cell Transplantation in Sickle Cell Disease"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4860-0796","authenticated-orcid":false,"given":"Mohammed","family":"Essa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9174-5803","authenticated-orcid":false,"given":"Mohsen","family":"Alzahrani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali D.","family":"Alahmari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmoud","family":"Aljurf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,10]]},"reference":[{"key":"10_CR1","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1111\/bjh.17311","volume":"192","author":"M Alzahrani","year":"2021","unstructured":"Alzahrani M, Damlaj M, Jeffries N, Alahmari B, Singh A, Rondelli D, Tisdale JF, Saraf SL, Hsieh MM (2021) Non-myeloablative human leukocyte antigen-matched related donor transplantation in sickle cell disease: outcomes from three independent centres. Br J Haematol 192:761\u2013768. https:\/\/doi.org\/10.1111\/bjh.17311","journal-title":"Br J Haematol"},{"key":"10_CR2","volume-title":"StatPearls [Internet]","author":"D Ashorobi","year":"2024","unstructured":"Ashorobi D, Naha K, Bhatt R (2024) Hematopoietic stem cell transplantation in sickle cell disease. [Updated 2023 Jul 19]. In: StatPearls [Internet]. StatPearls Publishing, Treasure Island"},{"issue":"10","key":"10_CR3","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1038\/bmt.2017.147","volume":"52","author":"A Balduzzi","year":"2017","unstructured":"Balduzzi A, Dalle JH, Jahnukainen K et al (2017) Fertility preservation issues in pediatric hematopoietic stem cell transplantation: practical approaches from the consensus of the Pediatric Diseases Working Party of the EBMT and the International BFM Study Group. Bone Marrow Transplant 52(10):1406\u20131415. https:\/\/doi.org\/10.1038\/bmt.2017.147","journal-title":"Bone Marrow Transplant"},{"issue":"18","key":"10_CR4","doi-asserted-by":"publisher","first-page":"3647","DOI":"10.1182\/blood-2012-04-383430","volume":"120","author":"SK Ballas","year":"2012","unstructured":"Ballas SK, Gupta K, Adams-Graves P (2012) Sickle cell pain: a critical reappraisal. Blood 120(18):3647\u20133656","journal-title":"Blood"},{"issue":"1","key":"10_CR5","doi-asserted-by":"publisher","first-page":"91","DOI":"10.3324\/haematol.2018.213207","volume":"105","author":"F Bernaudin","year":"2020","unstructured":"Bernaudin F, Dalle JH, Bories D et al (2020) Soci\u00e9t\u00e9 Fran\u00e7aise de Greffe de Moelle et de Th\u00e9rapie Cellulaire. Long-term event-free survival, chimerism and fertility outcomes in 234 patients with sickle-cell anemia younger than 30 years after myeloablative conditioning and matched-sibling transplantation in France. Haematologica 105(1):91\u2013101","journal-title":"Haematologica"},{"key":"10_CR6","doi-asserted-by":"publisher","first-page":"4285","DOI":"10.1182\/blood-2012-07-438408","volume":"120","author":"J Bola\u00f1os-Meade","year":"2012","unstructured":"Bola\u00f1os-Meade J, Fuchs EJ, Luznik L et al (2012) HLA-haploidentical bone marrow transplantation with posttransplant cyclophosphamide expands the donor pool for patients with sickle cell disease. Blood 120:4285\u20134291","journal-title":"Blood"},{"key":"10_CR7","doi-asserted-by":"publisher","first-page":"e183","DOI":"10.1016\/S2352-3026(19)30031-6","volume":"6","author":"J Bola\u00f1os-Meade","year":"2019","unstructured":"Bola\u00f1os-Meade J, Cooke KR, Gamper CJ et al (2019) Effect of increased dose of total body irradiation on graft failure associated with HLA-haploidentical transplantation in patients with severe haemoglobinopathies: a prospective clinical trial. Lancet Haematol 6:e183\u2013e193. https:\/\/pubmed.nc","journal-title":"Lancet Haematol"},{"issue":"12","key":"10_CR8","doi-asserted-by":"publisher","first-page":"e543","DOI":"10.3324\/haematol.2019.216788","volume":"104","author":"B Cappelli","year":"2019","unstructured":"Cappelli B, Volt F, Tozatto-Maio K, Scigliuolo GM, Ferster A, Dupont S, Sim\u00f5es BP, Al-Seraihy A, Aljurf MD, Almohareb F, Belendez C, Matthes S, Dhedin N, Pondarre C, Dalle JH, Bertrand Y, Vannier JP, Kuentz M, Lutz P, Michel G, Rafii H, Neven B, Zecca M, Bader P, Cavazzana M, Labopin M, Locatelli F, Magnani A, Ruggeri A, Rocha V, Bernaudin F, de La Fuente J, Corbacioglu S, Gluckman E, Eurocord, the Cellular Therapy and Immunobiology Working Party (CTIWP), and the Paediatric Diseases Working Party (PDWP) of the EBMT (2019) Risk factors and outcomes according to age at transplantation with an HLA-identical sibling for sickle cell disease. Haematologica 104(12):e543\u2013e546","journal-title":"Haematologica"},{"key":"10_CR9","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-031-44080-9_80","volume-title":"The EBMT handbook","author":"B Cappelli","year":"2024","unstructured":"Cappelli B, Gluckman E, Corbacioglu S, de la Fuente J, Abboud MR (2024) Hemoglobinopathies (sickle cell disease and thalassemia). In: Sureda A, Corbacioglu S, Greco R, Kr\u00f6ger N, Carreras E (eds) The EBMT handbook. Springer, Cham. https:\/\/doi.org\/10.1007\/978-3-031-44080-9_80"},{"issue":"6","key":"10_CR10","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1016\/j.bbmt.2018.11.027","volume":"25","author":"J de la Fuente","year":"2019","unstructured":"de la Fuente J, Dhedin N, Koyama T et al (2019) Haploidentical bone marrow transplantation with post-transplantation cyclophosphamide plus thiotepa improves donor engraftment in patients with sickle cell anemia: results of an international learning collaborative. Biol Blood Marrow Transplant 25(6):1197\u20131209","journal-title":"Biol Blood Marrow Transplant"},{"issue":"12","key":"10_CR11","doi-asserted-by":"publisher","first-page":"e902","DOI":"10.1016\/S2352-3026(20)30283-0","volume":"7","author":"J de la Fuente","year":"2020","unstructured":"de la Fuente J, Amrolia P et al (2020) The role of haematopoietic stem cell transplantation for sickle cell disease in the era of targeted disease-modifying therapies and gene editing. Lancet Haematol 7(12):e902\u2013e911","journal-title":"Lancet Haematol"},{"issue":"8","key":"10_CR12","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.1182\/bloodadvances.2019001142","volume":"4","author":"MR DeBaun","year":"2020","unstructured":"DeBaun MR, Jordan LC, King AA et al (2020) American Society of Hematology 2020 guidelines for sickle cell disease: prevention, diagnosis, and treatment of cerebrovascular disease in children and adults. Blood Adv 4(8):1554\u20131588. https:\/\/doi.org\/10.1182\/bloodadvances.2019001142","journal-title":"Blood Adv"},{"key":"10_CR13","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1111\/bjh.12737","volume":"165","author":"L Dedeken","year":"2014","unstructured":"Dedeken L, L\u00ea PQ et al (2014) Haematopoietic stem cell transplantation for severe sickle cell disease in childhood: a single centre experience of 50 patients. Br J Haematol 165:402\u2013408. https:\/\/doi.org\/10.1111\/bjh.12737","journal-title":"Br J Haematol"},{"issue":"11","key":"10_CR14","doi-asserted-by":"publisher","first-page":"e585","DOI":"10.1016\/S2352-3026(19)30154-1","volume":"6","author":"M Eapen","year":"2019","unstructured":"Eapen M, Brazauskas R, Walters MC et al (2019) Effect of donor type and conditioning regimen intensity on allogeneic transplantation outcomes in patients with sickle cell disease: a retrospective multicentre, cohort study. Lancet Haematol 6(11):e585\u2013e596","journal-title":"Lancet Haematol"},{"issue":"2","key":"10_CR15","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.hemonc.2019.12.006","volume":"13","author":"J Foell","year":"2020","unstructured":"Foell J, Kleinschmidt K, Jakob M, Troeger A, Corbacioglu S (2020) Alternative donor: \u03b1\u00df\/CD19 T-cell-depleted haploidentical hematopoietic stem cell transplantation for sickle cell disease. Hematol Oncol Stem Cell Ther 13(2):98\u2013105. https:\/\/doi.org\/10.1016\/j.hemonc.2019.12.006","journal-title":"Hematol Oncol Stem Cell Ther"},{"issue":"3","key":"10_CR16","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1056\/NEJMoa2031054","volume":"384","author":"H Frangoul","year":"2021","unstructured":"Frangoul H, Altshuler D, Cappellini MD et al (2021) CRISPR-Cas9 gene editing for sickle cell disease and \u03b2-thalassemia. N Engl J Med 384(3):252\u2013260. https:\/\/doi.org\/10.1056\/NEJMoa2031054","journal-title":"N Engl J Med"},{"key":"10_CR17","doi-asserted-by":"publisher","unstructured":"GBD 2021 Sickle Cell Disease Collaborators (2023) Global, regional, and national prevalence and mortality burden of sickle cell disease, 2000\u20132021: a systematic analysis from the Global Burden of Disease Study 2021 [published correction appears in Lancet Haematol. 2023 Aug;10(8):e574. https:\/\/doi.org\/10.1016\/S2352-3026(23)00215-6]. Lancet Haematol 10(8):e585\u2013e599. https:\/\/doi.org\/10.1016\/S2352-3026(23)00118-7","DOI":"10.1016\/S2352-3026(23)00215-6"},{"issue":"11","key":"10_CR19","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.1182\/blood-2016-10-745711","volume":"129","author":"E Gluckman","year":"2017","unstructured":"Gluckman E, Cappelli B, Bernaudin F et al (2017) Eurocord, the Pediatric Working Party of the European Society for Blood and Marrow Transplantation, and the Center for International Blood and Marrow Transplant Research. Sickle cell disease: an international survey of results of HLA-identical sibling hematopoietic stem cell transplantation. Blood 129(11):1548\u20131556","journal-title":"Blood"},{"issue":"5","key":"10_CR20","doi-asserted-by":"publisher","first-page":"e333","DOI":"10.1016\/S2352-3026(23)00011-X","volume":"10","author":"SA Grupp","year":"2023","unstructured":"Grupp SA et al (2023) Defibrotide plus best standard of care compared with best standard of care alone for the prevention of sinusoidal obstruction syndrome (HARMONY): a randomised, multicentre, phase 3 trial. Lancet Haematol 10(5):e333\u2013e345","journal-title":"Lancet Haematol"},{"issue":"11","key":"10_CR22","doi-asserted-by":"publisher","first-page":"1726","DOI":"10.2106\/00004623-199711000-00015","volume":"79","author":"P Hernigou","year":"1997","unstructured":"Hernigou P, Bernaudin F, Reinert P, Kuentz M, Vernant JP (1997) Bone-marrow transplantation in sickle-cell disease. Effect on osteonecrosis: a case report with a four-year follow-up. J Bone Joint Surg Am 79(11):1726\u20131730. https:\/\/doi.org\/10.2106\/00004623-199711000-00015","journal-title":"J Bone Joint Surg Am"},{"key":"10_CR23","doi-asserted-by":"publisher","first-page":"2309","DOI":"10.1056\/NEJMoa0904971","volume":"361","author":"MM Hsieh","year":"2009","unstructured":"Hsieh MM, Kang EM, Fitzhugh CD et al (2009) Allogeneic hematopoietic stem-cell transplantation for sickle cell disease. N Engl J Med 361:2309\u20132317","journal-title":"N Engl J Med"},{"key":"10_CR24","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1182\/blood-2011-01-332510","volume":"118","author":"MM Hsieh","year":"2011","unstructured":"Hsieh MM, Fitzhugh CD, Tisdale JF (2011) Allogeneic hematopoietic stem cell transplantation for sickle cell disease: the time is now. Blood 118:1197\u20131207. https:\/\/pubmed.ncbi.nlm.nih.gov\/21628400","journal-title":"Blood"},{"key":"10_CR25","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1056\/NEJM198409203111207","volume":"311","author":"FL Johnson","year":"1984","unstructured":"Johnson FL, Look AT, Gockerman J et al (1984) Bone-marrow transplantation in a patient with sickle-cell anemia. N Engl J Med 311:780\u2013783","journal-title":"N Engl J Med"},{"issue":"18","key":"10_CR26","doi-asserted-by":"publisher","first-page":"3668","DOI":"10.1182\/bloodadvances.2021004394C","volume":"5","author":"J Kanter","year":"2021","unstructured":"Kanter J, Liem RI, Bernaudin F et al (2021) American Society of Hematology 2021 guidelines for sickle cell disease: stem cell transplantation. Blood Adv 5(18):3668\u20133689","journal-title":"Blood Adv"},{"issue":"12","key":"10_CR27","doi-asserted-by":"publisher","first-page":"1810","DOI":"10.1016\/j.mayocp.2018.08.001","volume":"93","author":"S Kapoor","year":"2018","unstructured":"Kapoor S, Little JA, Pecker LH (2018) Advances in the treatment of sickle cell disease. Mayo Clin Proc 93(12):1810\u20131824. https:\/\/doi.org\/10.1016\/j.mayocp.2018.08.001","journal-title":"Mayo Clin Proc"},{"issue":"25","key":"10_CR28","doi-asserted-by":"publisher","first-page":"2654","DOI":"10.1182\/blood.2023023301","volume":"143","author":"AA Kassim","year":"2024","unstructured":"Kassim AA, de la Fuente J, Nur E, Wilkerson KL, Alahmari AD, Seber A, Bonfim C, Sim\u00f5es BP, Alzahrani M, Eckrich MJ, Horn B, Hanna R, Dhedin N, Rangarajan HG, Gouveia RV, Almohareb F, Aljurf M, Essa M, Alahmari B, Gatwood K, Connelly JA, Dovern E, Rodeghier M, DeBaun MR (2024) An international learning collaborative phase 2 trial for haploidentical bone marrow transplant in sickle cell disease. Blood 143(25):2654\u20132665. https:\/\/doi.org\/10.1182\/blood.2023023301","journal-title":"Blood"},{"issue":"11","key":"10_CR29","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1016\/j.bbmt.2008.08.016","volume":"14","author":"L Krishnamurti","year":"2008","unstructured":"Krishnamurti L, Kharbanda S, Biernacki MA, Zhang W, Baker KS, Wagner JE, Wu CJ (2008) Stable long-term donor engraftment following reduced-intensity hematopoietic cell transplantation for sickle cell disease. Biol Blood Marrow Transplant 14(11):1270\u20131278","journal-title":"Biol Blood Marrow Transplant"},{"issue":"6","key":"10_CR30","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1182\/blood-2013-03-489112","volume":"122","author":"F Locatelli","year":"2013","unstructured":"Locatelli F, Kabbara N, Ruggeri A et al (2013) Eurocord and European Blood and Marrow Transplantation (EBMT) group. Outcome of patients with hemoglobinopathies given either cord blood or bone marrow transplantation from an HLA-identical sibling. Blood 122(6):1072\u20131078","journal-title":"Blood"},{"issue":"6","key":"10_CR31","doi-asserted-by":"publisher","first-page":"325.e1","DOI":"10.1016\/j.jtct.2022.03.014","volume":"28","author":"AS Martin","year":"2022","unstructured":"Martin AS et al (2022) Long-term survival after hematopoietic cell transplant for sickle cell disease compared to the United States population. Transplant Cell Ther 28(6):325.e1\u2013325.e7","journal-title":"Transplant Cell Ther"},{"issue":"21","key":"10_CR32","doi-asserted-by":"publisher","first-page":"2715","DOI":"10.1182\/blood.V124.21.2715.2715","volume":"124","author":"S Ngo","year":"2014","unstructured":"Ngo S, Bartolucci P, Lobo D et al (2014) Causes of death in sickle cell disease adult patients: old and new trends [abstract]. Blood 124(21):2715","journal-title":"Blood"},{"issue":"3","key":"10_CR33","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1056\/NEJMoa1715971","volume":"379","author":"Y Niihara","year":"2018","unstructured":"Niihara Y, Miller ST, Kanter J et al (2018) A phase 3 trial of l-glutamine in sickle cell disease. N Engl J Med 379(3):226\u2013235. https:\/\/doi.org\/10.1056\/NEJMoa1715971","journal-title":"N Engl J Med"},{"key":"10_CR36","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1001484","volume":"10","author":"FB Piel","year":"2013","unstructured":"Piel FB, Hay SI, Gupta S et al (2013a) Global burden of sickle cell anaemia in children under five, 2010\u20132050: modelling based on demographics, excess mortality, and interventions. PLoS Med 10:e1001484","journal-title":"PLoS Med"},{"issue":"9861","key":"10_CR37","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/S0140-6736(12)61229-X","volume":"381","author":"FB Piel","year":"2013","unstructured":"Piel FB et al (2013b) Global epidemiology of sickle haemoglobin in neonates: a contemporary geostatistical model-based map and population estimates. Lancet 381(9861):142\u2013151","journal-title":"Lancet"},{"issue":"1","key":"10_CR38","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJM199107043250103","volume":"325","author":"OS Platt","year":"1991","unstructured":"Platt OS, Thorington BD, Brambilla DJ et al (1991) Pain in sickle cell disease. Rates and risk factors. N Engl J Med 325(1):11\u201316","journal-title":"N Engl J Med"},{"issue":"3","key":"10_CR39","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/0002-9343(78)90772-6","volume":"65","author":"D Powars","year":"1978","unstructured":"Powars D, Wilson B, Imbus C, Pegelow C, Allen J (1978) The natural history of stroke in sickle cell disease. Am J Med 65(3):461\u2013471","journal-title":"Am J Med"},{"key":"10_CR40","doi-asserted-by":"publisher","unstructured":"Rostami T, Rad S, Rostami MR et al (2024) Hematopoietic stem cell transplantation in sickle cell disease: a multidimentional review. Cell Transplant 33. https:\/\/doi.org\/10.1177\/09636897241246351","DOI":"10.1177\/09636897241246351"},{"key":"10_CR41","unstructured":"Saib I et al (2020) EBMT abstract"},{"issue":"5","key":"10_CR42","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1177\/2040620713483063","volume":"4","author":"S Shenoy","year":"2013","unstructured":"Shenoy S (2013) Hematopoietic stem-cell transplantation for sickle cell disease: current evidence and opinions. Ther Adv Hematol 4(5):335\u2013344","journal-title":"Ther Adv Hematol"},{"issue":"21","key":"10_CR43","doi-asserted-by":"publisher","first-page":"2561","DOI":"10.1182\/blood-2016-05-715870","volume":"128","author":"S Shenoy","year":"2016","unstructured":"Shenoy S, Eapen M, Panepinto JA, Logan BR, Juan W, Abraham A, Brochstein J, Chaudhury S, Godder K, Haight AE, Kasow KA, Leung K, Andreansky M, Bhatia M, Dalal J, Haines H, Jaroscak J, Lazarus HM, Levine JE, Krishnamurti L, Margolis D, Megason GC, Yu LC, Pulsipher MA, Gersten I, DiFronzo N, Horowitz MM, Walters MC, Kamani N (2016) A trial of unrelated donor marrow transplantation for children with severe sickle cell disease. Blood 128(21):2561\u20132567. https:\/\/doi.org\/10.1182\/blood-2016-05-715870","journal-title":"Blood"},{"issue":"14","key":"10_CR44","doi-asserted-by":"publisher","first-page":"3457","DOI":"10.1182\/bloodadvances.2020001469","volume":"4","author":"MJ Telen","year":"2020","unstructured":"Telen MJ (2020) Curative vs targeted therapy for SCD: does it make more sense to address the root cause than target downstream events? Blood Adv 4(14):3457\u20133465","journal-title":"Blood Adv"},{"issue":"21","key":"10_CR45","doi-asserted-by":"publisher","first-page":"4579","DOI":"10.1182\/blood.V122.21.4579.4579","volume":"122","author":"D Thompson","year":"2013","unstructured":"Thompson D, Harrington Y, de la Fuente J (2013) The incidence of posterior reversible encephalopathy syndrome is increased in BMT for Haemoglobinopathies. Blood 122(21):4579. https:\/\/doi.org\/10.1182\/blood.V122.21.4579.4579","journal-title":"Blood"},{"issue":"6","key":"10_CR46","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1056\/NEJMoa1903212","volume":"381","author":"E Vichinsky","year":"2019","unstructured":"Vichinsky E, Hoppe CC, Ataga KI et al (2019) A phase 3 randomized trial of voxelotor in sickle cell disease. N Engl J Med 381(6):509\u2013519. https:\/\/doi.org\/10.1056\/NEJMoa1903212","journal-title":"N Engl J Med"},{"key":"10_CR47","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1056\/NEJM199608083350601","volume":"335","author":"MC Walters","year":"1996","unstructured":"Walters MC, Patience M, Leisenring W et al (1996) Bone marrow transplantation for sickle cell disease. N Engl J Med 335:369\u2013376. https:\/\/pubmed.ncbi.nlm.nih.gov\/8663884","journal-title":"N Engl J Med"},{"issue":"10","key":"10_CR48","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1001\/jama.2014.10517","volume":"312","author":"BP Yawn","year":"2014","unstructured":"Yawn BP, Buchanan GR, Afenyi-Annan AN et al (2014) Management of sickle cell disease: summary of the 2014 evidence-based report by expert panel members. JAMA 312(10):1033\u20131048","journal-title":"JAMA"}],"container-title":["Advances in Experimental Medicine and Biology","Clinical Management of Challenges in Allogeneic Stem Cell Transplant"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-031-84988-6_10","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,9]],"date-time":"2025-06-09T06:56:10Z","timestamp":1749452170000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-3-031-84988-6_10"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"ISBN":["9783031849879","9783031849886"],"references-count":44,"URL":"https:\/\/doi.org\/10.1007\/978-3-031-84988-6_10","relation":{},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"value":"0065-2598","type":"print"},{"value":"2214-8019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025]]},"assertion":[{"value":"10 June 2025","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}